The cellular 300 kDa protein known as p300 is a target for the adenoviral E1A oncoprotein and it is thought to participate in prevention of the G 0 /G 1 transition during the cell cycle, in activation of certain enhancers and in the stimulation of differentiation pathways. In order to determine the exact function of p300, as a first step we constructed a simple assay system for the selection of a potential target site of a hammerhead ribozyme in vivo. For the detection of ribozyme-mediated cleavage, we used a fusion gene (p300-luc) that consisted of the sequence encoding the N-terminal region of p300 and the gene for luciferase, as the reporter gene. We were also interested in the correlation of the GUX rule, for the triplet adjacent to the cleavage site, with ribozyme activity in vivo. Therefore, we selected five target sites that all included GUX. The rank order of activities in vitro indeed followed the GUX rule; with respect to the k cat , a C residue as the third base (X) was the best, next came an A residue and a U residue was the worst (GUC > GUA > GUU). However, in vivo the tRNA Val promoterdriven ribozyme, targeted to a GUA located upstream of the initiation codon, had the highest inhibitory effect (96%) in HeLa S3 cells when the molar ratio of the DNA template for the target p300 RNA to that for the ribozyme was 1:4. Since the rank order of activities in vivo did not conform to the GUX rule, it is unlikely that the rate limiting step for cleavage of the p300-luc mRNA was the chemical step. This kind of ribozyme expression system should be extremely useful for elucidation of the function of p300 in vivo.
INTRODUCTION
Elucidation of the functions and the site of interaction with their targets of transcription factors is of considerable current interest (1) (2) (3) . A 300 kDa cellular protein, known as p300, is a nuclear phosphoprotein that is the binding target of the adenovirus E1A oncoprotein (4) . The region of E1A required for binding of p300 includes residues at the N-terminus and in CR1 (conserved region 1) of the E1A oncoprotein (5) . Binding of p300 to E1A is believed to stimulate the G 0 /G 1 transition, to block differentiation and to inhibit the action of certain transcriptional enhancer elements (5) . Other data support the view that p300 plays a role as a co-activator (6) (7) (8) (9) (10) (11) (12) and the p300 protein has been shown to activate transcription when fused to a DNA binding domain (7, 8) . However, the functional significance of p300 protein in vivo is still unknown. Thus, we decided to construct a system in which expression of p300 was regulated by a hammerhead ribozyme.
Recently, regulation of gene expression by ribozyme and antisense RNA/DNA has been performed (13) (14) (15) (16) (17) . The principle of catalytic self-cleavage of RNA molecules and of cleavage in trans has been well established over the last decade (18) . Expression of various genes has been suppressed by ribozymes (13) (14) (15) (16) (17) (18) (19) (20) (21) and among the RNA molecules with ribozyme activity, the hammerhead ribozyme is the best characterized (22) (23) (24) (25) (26) (27) (28) . It is well established that ribozymes require divalent metal ions for cleavage activity in vitro and in vivo (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) . Theoretically, it is possible for one molecule of ribozyme to cleave multiple target RNAs. On the other hand, for high level activity, an antisense RNA needs a cellular factor, such as an RNase III-type nuclease, to destroy the target RNA. As a consequence, a ribozyme tends to show a higher inhibitory effect than does an antisense RNA (39) .
The activity of ribozymes depends very strongly on the target site and, furthermore, it is not easy to predict the best cleavable target site. Both primary (40) (41) (42) (43) and secondary structural rules (44) must be considered in selection of the target site. In general, the GUC triplet should be suitable as a cleavage site, since it conforms to the NUX rule, where N is A, U, G or C and X is A, U or C (40) (41) (42) (43) (44) (45) (46) (47) , and since it is the most popular triplet used in nature (24, 43) . In addition, the tertiary structure of the target RNA in vivo (including interaction with cellular proteins) should also be considered in selecting the target site, since it has a strong influence on the activity of ribozymes and antisense molecules. Unfortunately, it is difficult to predict the in vivo tertiary structure of the cleavage site, even though the selected site is in accord with the primary and secondary structural rules. As a result, selection of the best target site remains a matter of trial and error.
Another challenge for in vivo application of ribozymes is construction of a gene for a ribozyme that allows continuous expression of the ribozyme in a particular cell. Despite an increasing number of successful studies, based on general rules for antisense sequences and on sophisticated constructs for the expression of ribozymes, the design of ribozymes that cleave RNA in vivo is also a matter of trial and error.
Our previous kinetic studies in vitro demonstrated that in reactions catalyzed by a trans-acting hammerhead ribozyme, mutant substrates that contained a GUA or GUU triplet at the cleavage site were cleaved less efficiently than a wild-type substrate with the GUC triplet (42) . For our analysis of the function of p300 using a ribozyme that would significantly suppress expression of p300 in vivo, we needed an appropriate combination of a good target site and a ribozyme expression system. We chose luciferase activity as a reporter and linked the sequence that encoded the N-terminal region (285 nt in length) of p300 to the gene for luciferase. In general, the N-terminal region is the first choice for the target site of ribozymes and antisense molecules (39) . We were also interested in the correlation of the GUX (X = A, U or C) rule, derived on the basis of studies in vitro (42) , with ribozyme activity in vivo. Therefore, we chose five different target sites which contained the GUC, GUA or GUU triplet within this N-terminal region and the efficiency of cleavage at each site was examined in vitro and in vivo in a transient co-transfection assays in HeLa S3 cells.
We report here that all ribozymes whose synthesis was driven by the tRNA Val promoter significantly suppressed expression of the p300-luc fusion gene, with the exception of the inactive ribozyme control. Since the inactive ribozyme control did not have any inhibitory effect, the observed activities appeared to originate from the cleavage activities of the ribozymes. Moreover, since the rank order of activities in vivo did not conform to the recently established GUX rule (41, 42) , it is unlikely that the rate limiting step for cleavage of the p300-luc mRNA in vivo was the chemical step. Most importantly, in this study a significant inhibitory effect was observed when the molar ratio of the DNA template for the target p300 mRNA to that for the ribozyme was only 1:1. Therefore, this kind of ribozyme system should be a useful tool to elucidate the function of p300 in vivo.
MATERIALS AND METHODS

Synthesis of oligonucleotides, ribozymes and substrates
Oligonucleotides were synthesized with a DNA/RNA synthesizer (model 392; Applied Biosystems, Foster City, CA) and purified on OPC columns. Ribozymes and their corresponding substrates used for kinetic measurements in vitro were synthesized with a DNA/RNA synthesizer (model 392; Applied Biosystems) and purified by polyacrylamide gel electrophoresis as described previously (36, 38, 42, 48, 49) . Reagents for manipulation of RNA were purchased from either ABI or American Bionetics Inc. (ABN; Foster City, CA). Sequences of the synthetic ribozymes and their corresponding substrates were as follows: Ribozyme 1 (R1), 5′-GAG GAA CUG AUG AGG ACC GAA AGG UCG AAA CCA GA-3′; Ribozyme 2 (R2), 5′-CGG AGA CUG AUG AGG ACC GAA AGG UCG AAA CAA GC-3′; Ribozyme 3 (R3), 5′-CUG GCG CUG AUG AGG ACC GAA AGG UCG AAA CGC CG-3′; Ribozyme 4 (R4), 5′-UGC CAA CUG AUG AGG ACC GAA AGG UCG AAA CUU GU-3′; Ribozyme 5 (R5), 5′-AUC UUG CUG AUG AGG ACC GAA AGG UCG AAA CCA UG-3′; Substrate 1 (S1), 5′-UCU GGU UUU CCU C-3′; Substrate 2 (S2), 5′-GCU UGU AUC UC CG-3′; Substrate 3 (S3), 5′-CGG CGU CCG CCA G-3′; Substrate 4 (S4), 5′-ACA AGU CUU GGC A-3′; Substrate 5 (S5), 5′-CAU GGU ACA AGA U-3′.
Kinetic measurements in vitro
Reaction rates in vitro were measured at 37_C in 10 mM MgCl 2 and 50 mM Tris-HCl, pH 6.0, under ribozyme saturating (single turnover; the final concentration of each ribozyme was 100 nM) conditions with 5′-32 P-labeled substrate (the final concentration of each substrate was 10 nM). Reactions were stopped by removal of aliquots from the reaction mixture after 10 min incubation and mixing with an equivalent volume of a solution of 100 mM EDTA, 9 M urea, 0.1% xylene cyanol and 0.1% bromophenol blue. Substrates and 5′-cleaved products were separated by electrophoresis on a 20% polyacrylamide-7 M urea denaturing gel and were detected by autoradiography (Fig. 2 ). The extent of cleavage was determined by quantitation of radioactivity in the bands of the substrate and product with a Bio-Image Analyzer (BA2000; Fuji Film, Tokyo).
Construction of a plasmid for expression of the p300-luc fusion gene
For the detection of ribozyme-mediated cleavage, we used a fusion gene (p300-luc) that consisted of the sequence encoding the N-terminal region of p300 and the gene for luciferase, as the reporter gene. The plasmid for expression of the p300-luc fusion gene was constructed from the Pica Genet Luciferase Control Vector (Control Vector; Toyoinki, Tokyo). In brief, the DNA fragment encoding the N-terminal region of p300 (nt 1146-1430) was amplified from pCMVb p300 (6) by PCR with 5′-AAT TCG ATA AGC TTG AGA TTT CCT GAG GAT TCT GGT TTT-3′ as the 5′ primer and 5′-TAG GCC GCT CTA GAG GAT AGA ATG GCG CCG GGC CTT TCT TTA TGT TTT TAG AAG CTG CAT CTT GTA CCA TG-3′ as the 3′ primer. After digestion with HindIII and XbaI, this fragment was inserted into the HindIII and XbaI sites of the Control Vector. The nucleotide sequence of the p300-luc fusion gene was confirmed by sequencing.
Construction of plasmids for expression of a hammerhead ribozyme and antisense RNA
Chemically synthesized oligonucleotides encoding ribozyme 2, inactive ribozyme 2 or antisense 2 ( Fig. 1C ) and the pol III termination sequence (50) were convered to double-stranded sequences by PCR. After digestion with Csp45I and SalI, the fragments were cloned downstream of the tRNA promoter of pUC-tRVP (which contains the chemically synthesized promoter for human tRNA Val between the EcoRI and SalI sites of pUC19). The sequences of all constructs were confirmed by direct sequencing.
Cell culture and transfection
HeLa S3 cells were cultured in Dulbecco's modified Eagle's medium containing 10% (v/v) fetal bovine serum, 100 µg/ml penicillin and 100 µg/ml streptomycin. Transfections with plasmid DNA were performed using Lipofectin (Gibco BRL, Gaithersburg, MD) in accordance with the manufacturer's protocol. In brief, 3 × 10 5 cells were plated in 6-well plates 1 day before transfection. After cells had been washed twice with phosphate-buffered saline (PBS), 0.8 ml OPTI-MEM I medium (Gibco BRL) was added to each well. A solution of plasmid DNA (6 µg plasmid DNA in 100 µl OPTI-MEM I medium) and a solution of Lipofectin (4 µl Lipofectin reagent in 100 µl OPTI-MEM I medium) were mixed gently and the mixture was kept at room temperature for 20 min to allow formation of Lipofectin-DNA complexes. The solution of Lipofectin-DNA complexes was added to the cells. After 12 h, the medium was removed and 2 ml of the growth medium were added. The cultures were incubated for an additional 24 h.
Measurement of luciferase activity
Transfected cells were washed twice with PBS and lysed in lysis buffer (Tris-PO 4, pH 7.8, 8 mM MgCl 2 , 1 mM DTT, 1 mM EDTA, 1% Triton X-100, 1% BSA and 15% glycerol). After 
Northern blot analysis
Total cellular RNA was isolated from transfected cells as described by Chomczynski and Sacchi (52) . RNA (10 µg), denatured with glyoxal (53), was fractionated on a 2.2% agarose gel, transferred to a nylon membrane (Hybond-N; Amersham, UK) and allowed to hybridize with a 5′-32 P-end-labeled oligonucleotide probe (5′-CTC GCT TGT TTC GGA CCT TT-3′, specific for ribozyme 2 and inactive ribozyme 2, or 5′-CTC GCT TGT ATC TCC GAA A-3′, specific for antisense 2; Fig. 1C ).
RESULTS AND DISCUSSION
Construction of a plasmid (p300-luc) that encodes the N-terminal region of p300 and luciferase
The exact function of the cellular protein p300 remains obscure. In order to suppress the expression of p300, we tried to identify the best target site within the p300 transcript for ribozyme-mediated cleavage. Since the phenotype of suppressed p300 clones cannot be used for quantitation of the efficiency of ribozyme-mediated cleavage and, moreover, since the cleavage products, in general, cannot be detected in vivo, we constructed a rapid assay system for selection of the best target site by fusing the N-terminal region of the gene for p300 (corresponding to nt 1146-1430, according to the numbering of Eckner et al.; 6) in-frame with the gene for luciferase (Fig. 1A) . The fused gene product was produced under the control of the SV40 promoter and its enhancer.
Construction of pol III-driven ribozyme and antisense expression plasmids
In a previous study, we examined the generality of the NUX rule (where N is A, U, G or C and X is A, U or C) and we demonstrated from kinetic studies in vitro that in reactions catalyzed by trans-acting hammerhead ribozymes, mutant substrates that contained the GUA or GUU triplet were cleaved less efficiently than the wild-type substrate with the GUC triplet (GUG could not be cleaved; 42). In choosing potential target sites for examination of the efficiency of their ribozyme-mediated cleavage in vivo, we made sure that each of the selected conserved sites contained one of all possible GUX triplets.
The five selected target sites are indicated in Figure 1A and the corresponding ribozymes are numbered 1-5 in the upstream to downstream direction. Each of the ribozymes was transcribed under the control of the human tRNA Val promoter (Fig. 1B) . Each ribozyme had the same 24 nt catalytic domain as that refined by Haseloff and Gerlach (43) and each was equipped with nine bases on both substrate binding arms that were targeted to the relatively well-conserved sequences of p300 mRNA.
Since ribozyme 2 targeted to the GUA site was found to be the most active (see below), constructs with an inactive ribozyme and an antisense control targeted to the same site were generated (Fig. 1C) . The inactive ribozyme differed from the active ribozyme by a single G 5 →A mutation in the catalytic core (the numbering system follows the rule for hammerhead ribozymes; 54). This single base change should diminish the cleavage activity while the antisense effect, if any, should be unaffected (39, 40) . As a second control for comparison of the activity of ribozyme 2 with that of an antisense RNA, we synthesized an antisense construct in which the entire catalytic domain of ribozyme 2 was replaced by a single uracil moiety (Fig. 1C) .
Re-examination of the GUX rule in vitro
In a previous study, in order to examine in detail the generality of the NUX rule for the GUC triplet adjacent to the cleavage site in hammerhead ribozymes, kinetic parameters were determined for substrates with mutations only within this triplet (42) . In the present study, sequences of the selected five target sites differed not only in the GUX triplet, but also in the binding sites. In order to examine whether activities in vitro of the five ribozymes selected in this study might follow the GUX rule, we chemically synthesized five ribozymes (R1-R5) and their corresponding substrates (S1-S5) and relative activities were measured under single turnover conditions. In this case, each synthetic ribozyme was equipped with six bases on both substrate binding arms (complete sequences are listed in Materials and Methods).
Results of such studies are shown in Figure 2 . The level of cleavage (%) in 10 min in 10 mM MgCl 2 and 50 mM Tris-HCl, pH 6.0, at 37_C was 5, 20, 25, 27 and 12% respectively, for R1/S1 (GUU), R2/S2 (GUA), R3/S3 (GUC), R4/S4 (GUC) and R5/S5 (GUA). The order of efficiency of cleavage was as follows: R4 (GUC) > R3 (GUC) > R2 (GUA) > R5 (GUA) > R1 (GUU), where the target triplet is indicated in parentheses. Therefore, the rank order of activities in vitro followed the GUX rule; a C residue as the third base (X) was the best, next came an A residue and a U residue was the worst (GUC > GUA > GUU).
Suppression of expression of the p300-luc fusion gene: results of transient transfection assays
The effects of the ribozymes, produced in trans, on the specific target mRNA, namely the transcript of the p300-luc fusion gene, were examined by measuring luciferase activity in HeLa S3 cells that had been co-transfected with the plasmids that encode the ribozymes and the p300-luciferase (pUC-tRR and p300-luc plasmids respectively). To determine the effectiveness of ribozymemediated inhibition of expression of the p300-luc fusion gene in the transient expression assay, a control plasmid (pUC-tRVP), namely pUC-tRR from which the ribozyme sequence had been deleted (Fig. 1B) , was used to allow generation of luciferase activity that was designated 100%. As shown in Figure 3 , all the active ribozymes were capable of decreasing luciferase activity in vivo. The results shown are averages of results from five sets of experiments and are given as percentages relative to the control value of 100%. The extent of inhibition by ribozymes expressed from the pol III promoter varied from 47 to 96% when the molar ratio of template DNAs for the target and the ribozyme was 1:4. To the best of our knowledge, this is the lowest ratio ever reported to yield a significant inhibitory effect and it proves the utility of the pol III promoter in mammalian cells (55, 56) .
The order of efficiency of cleavage was as follows: R2 (GUA) > R5 (GUA) > R1 (GUU) > R4 (GUC) > R3 (GUC), where the target triplet is indicated in parentheses. These results would not have been predicted from the cleavage activity of NUX triplets in the trans system (42; Fig. 2 ) and they suggest, in turn, that accessibility of the target site governs the effectiveness of the ribozyme. Since the accessibility of the target site is not easily predictable, the generation of ribozymes that cleave RNA in vivo remains, unfortunately, a matter of trial and error. However, a system for the rapid evaluation of ribozyme activity in vivo, such as the one described herein, is of obvious value.
Ribozyme specificity in the suppression of expression of the p300-luc fusion gene
Since ribozyme 2 was found to be the most effective ribozyme (Fig. 3) , we examined its antisense effect using the inactive ribozyme control. Furthermore, the inhibitory effect of the ribozyme was compared with that of antisense RNA targeted to the same site. Since the antisense RNA was significantly shorter than the ribozyme, levels of expression of ribozyme 2, inactive ribozyme 2 and antisense 2 RNA were examined by Northern blotting (Fig. 4) . The levels of expression were determined by quantitation of the radioactivity of bands with an image analyzer. The levels of expression were found to be nearly identical in each of the three cases, within the limits of experimental error (Fig. 4) .
The three constructs were examined for their ability to suppress expression of the p300-luc fusion gene, as described in the previous section. As shown in Figure 5A , the inactive ribozyme did not have any inhibitory effect, in accord with our previous finding in a bacterial system (39) . The expected stability of RNA duplexes is as follows: antisense > inactive ribozyme [ active ribozyme. The significant inhibition by the antisense RNA was in accord with this prediction. Moreover, the RNase III-type activity of the host cells should increase the inhibitory effect of the antisense RNA. Since the inactive ribozyme (which, with its target site duplex, would not be expected to be a substrate for RNase III-type ribonucleases because of the discontinuous base pairing) did not have any inhibitory effect, it seems likely that the inhibitory effects of the ribozyme originated from its cleavage activity.
The suppressive effects of the ribozyme constructs on luciferase activity were apparently specific. To confirm the specificity of the ribozyme, an independent reporter gene, namely the gene for luciferase without the region that encoded the N-terminal sequence of p300 (Pica Genet Luciferase Control Vector) under the control of the SV40 promoter, was also used to co-transfect HeLa S3 cells. The luciferase activity (%) is shown in Figure 5B . When the Pica Genet Luciferase Control Vector plasmid was used to co-transfect cells with the ribozyme coding sequence plasmid, the luciferase activity (Fig. 5B, lane c) was the same as that obtained by co-transfection with the Pica Gene ª Luciferase Control Vector plasmid and the plasmid from which the ribozyme sequence had been deleted (Fig. 5B, lane d) , namely no inhibition of luciferase activity was observed (Fig. 5B, lanes c and d) . In contrast, when the N-terminal coding p300-luc plasmid was co-transfected with the ribozyme coding plasmid (Fig. 5B, lane  a) , the luciferase activity was almost two orders of magnitude lower than that obtained after co-transfection of the N-terminal coding p300-luc plasmid and the plasmid from which the ribozyme sequence had been deleted (Fig. 5B, lane b) . In other words, almost complete inhibition of expression of the p300-luciferase fusion gene was observed (Fig. 5B, lanes a and b) . These results clearly confirm the specificity of action of the ribozyme constructs on expression of p300-luc.
Finally, we examined the dependence on concentration of the inhibition of luciferase activity. As shown in Figure 6 , significant inhibition was detectable even when equimolar amounts of template DNAs for the target and the ribozyme were used. Similar results were obtained with the antisense RNA coding plasmid.
However, the inactive ribozyme coding plasmid did not have any inhibitory effect (average inhibition 4%).
In conclusion, we have demonstrated that: (i) the p300-luc assay system described here is a simple system in which potential target sites can be easily identified; (ii) ribozyme 2 under the control of the pol III (tRNA Val ) promoter effectively suppressed expression of the p300-luc fusion gene (96%). Exploiting these results, we shall now use this ribozyme 2 system to elucidate details of the function of p300 in vivo. To this end, we are isolating stable transformants that generate pol III-derived (tRNA Val -derived) ribozyme 2 in our laboratory.
